Siemens, takes on Prowess DAO tech
This article was originally published in Clinica
Siemens Healthcare has teamed up with radiotherapy company Prowess in a bid to develop new radiation oncology treatment planning software. The exclusive partnership will see Siemens integrate into its linear accelerators Prowess' direct aperture optimisation (DAO) technology. The DAO technology allows clinicians to make on-line corrections to the treatment plan based on pre-treatment CT scans, just before the patient is about to receive therapy. This combination is designed to help users reduce the amount of equipment in the workplace and cut down overall treatment times. Chico, California-based Prowess is currently developing the DAO-based Plan-to-Patient software for radiation therapy, which is undergoing clinical assessment and is scheduled to become commercially available in Q2 2008. According to Siemens, the Plan-to-Patient device works in conjunction with its CTVision system, an image-guided radiation therapy device.
You may also be interested in...
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.
Laparoscopic power morcellation to remove uterine fibroids should only be performed with the use of a compatible containment system, and only on women younger than 50, the US FDA said in a newly published safety communication and draft guidance document. See what the president of the gynecologic trade group AAGL, Jubilee Brown, said about it here.